June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
CD14 participates in the regulation of retinal phagocytosis by retinal pigment epithelial cells as a co-receptor
Author Affiliations & Notes
  • Leila DHAOUI HAJEM
    Therapeutics, Institut de la vision, Paris, Île-de-France, France
  • Julie Enderlin
    Therapeutics, Institut de la vision, Paris, Île-de-France, France
  • Emeline F Nandrot
    Therapeutics, Institut de la vision, Paris, Île-de-France, France
  • Footnotes
    Commercial Relationships   Leila DHAOUI HAJEM None; Julie Enderlin None; Emeline Nandrot None
  • Footnotes
    Support  This work is supported by project grants to E.F.N. from the French State programs "Investissements d'Avenir” managed by the Agence Nationale de la Recherche [LIFESENSES: ANR-10-LABX-65; IHU FOReSIGHT: ANR-18-IAHU-0001], and from the Agence Nationale de la Recherche “Projet de Recherche Collaborative” program [ANR-17-CE14-0044-01].
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3001. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Leila DHAOUI HAJEM, Julie Enderlin, Emeline F Nandrot; CD14 participates in the regulation of retinal phagocytosis by retinal pigment epithelial cells as a co-receptor. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3001.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In the retina, the circadian elimination of aged photoreceptor outer segment (POS) by cells from the retinal pigment epithelium (RPE) is based on the recognition of phosphatidylserines, apoptotic eat-me signals displayed by their most aged extremities. Cluster of Differentiation 14 (CD14) and the InterCellular Adhesion Molecule 3 (ICAM3) are involved in the clearance of apoptotic cells by macrophages and are also expressed by RPE cells. We thus set out to characterize their potential participation in the regulation of the daily phagocytosis of photoreceptor outer segment (POS), alone or as co-receptors.

Methods : In vitro, inhibition assays (siRNA, blocking antibodies and pharmacological molecules) and immunofluorescence co-labelings of candidate receptors with POS were performed on the rat RPE-J cell line. In vivo, circadian mRNA expression patterns of candidates were studied using RT-qPCR on mouse RPE/choroid tissues from control mice sacrificed at different times of the light:dark cycle.

Results : CD14 siRNA transfection decreased POS phagocytosis, an effect that was counteracted by the co-transfection of ICAM3 or TLR4 siRNAs. Similarly, the use of the baicalin and IAXO-102 antagonists –that affect CD14-TLR4 signaling by decreasing the expression of CD14 and inhibiting the CD14-TLR4 signaling pathways, respectively– modified POS binding and internalization by RPE cells. The ICAM inhibitor BMS 688521 only affected POS tethering and to a limited extent. Upon POS challenge, CD14 expression levels at the cell surface increase, the receptors form clusters and directly co-localize with POS at 3 and 5 hours of phagocytosis. In contrast, ICAM3 receptors do not seem to directly interact with POS. In vivo, CD14 qPCR analysis show 2 peaks of expression at ZT3, just after the time of peak phagocytosis, and at ZT8.

Conclusions : Taken together, our current data suggest that CD14 may be involved in the regulation of POS phagocytosis by RPE cells, potentially in association with other receptors such as TLR4 and/or ICAM3. Further investigations such as in vitro receptor co-localization during phagocytosis and in vivo expression analysis by immunoblots and immunolabelings on RPE flatmounts at different times of the day are being performed in order to fully understand the exact participation of both receptors to this crucial function.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×